Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus oral aspirin in STEMI patients undergoing primary PCI
2015-001189-24Phase 3Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin in acute ST-segment elevation myocardial infarction (STEMI) and myocardial infarction (MI) (2 arms), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Rate of patients with ARU > 550 U. Started Sep 2021; status: terminated.
02
Drugs
aspirin
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)myocardial infarction (MI)
Beyond the preview
Go deeper on 2015-001189-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001189-24.